Atlas Trials

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

Clinical trial NCT02791308 · COMPLETED

Trial details

NCT number
NCT02791308
Sponsor
Actavis Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2015-02-01
Primary completion
2016-07-01
Enrollment
587

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.